Display options
Share it on

Indian J Crit Care Med. 2014 Apr;18(4):250-2. doi: 10.4103/0972-5229.130580.

Posterior reversible encephalopathy syndrome in a patient of organophosphate poisoning.

Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine

Rajesh Phatake, Sameer Desai, Manikanth Lodaya, Shrinivas Deshpande, Nagaraj Tankasali

Affiliations

  1. Lifeline24 × 7Intensive Care Unit, Hubli, Karnataka, India.
  2. Department of Anesthesiology, SDM Medical College Hospital, Dharwar, India.

PMID: 24872658 PMCID: PMC4033862 DOI: 10.4103/0972-5229.130580

Abstract

A 32-year-old male presented with a history of consuming some organophosphorous compound with suicidal intention. He was treated with atropine, pralidoxime, ventilator support. During stay patient had persistent irritability, tachycardiaand hypertension despite sedation and labetalol infusion. He developed headache, visual blurring hemiparesis and focal seizures. Magnetic resonance imaging of the brain revealed multifocal hyperintensities mainly in subcortical areas of parietal and occipital regions in T2-weighted images, with increased values of Apparent Diffusion Coefficient, suggesting posterior reversible encephalopathy syndrome (PRES). The possibilities of PRES caused by organophosphorous poisoning either due to hypertension caused by autonomic deregulation or direct neurological toxicity has been discussed.

Keywords: Organophosphorous poisoning; poisoning; posterior reversible encephalopathy syndrome

References

  1. Neurol India. 2000 Dec;48(4):308-13 - PubMed
  2. Singapore Med J. 2004 Aug;45(8):385-9 - PubMed
  3. AJNR Am J Neuroradiol. 2008 Jun;29(6):1043-9 - PubMed
  4. AJNR Am J Neuroradiol. 2008 Jun;29(6):1036-42 - PubMed
  5. Neurol India. 2009 Mar-Apr;57(2):119-25 - PubMed

Publication Types